KRAS Mutations and Primary Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib

BACKGROUND: Somatic mutations in the gene for the epidermal growth factor receptor (EGFR) are found in adenocarcinomas of the lung and are associated with sensitivity to the kinase inhibitors gefitinib (Iressa) and erlotinib (Tarceva). Lung adenocarcinomas also harbor activating mutations in the dow...

Descripción completa

Detalles Bibliográficos
Autores principales: Pao, William, Wang, Theresa Y, Riely, Gregory J, Miller, Vincent A, Pan, Qiulu, Ladanyi, Marc, Zakowski, Maureen F, Heelan, Robert T, Kris, Mark G, Varmus, Harold E
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2005
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC545207/
https://www.ncbi.nlm.nih.gov/pubmed/15696205
http://dx.doi.org/10.1371/journal.pmed.0020017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC545207/
https://www.ncbi.nlm.nih.gov/pubmed/15696205
http://dx.doi.org/10.1371/journal.pmed.0020017

Ejemplares similares